FREE Account Opening + No Clearing Fees
Loading...

Atmastco IPO vs Zenith Drugs IPO

Comparision between Atmastco IPO and Zenith Drugs IPO.

IPO Details

Atmastco IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Zenith Drugs IPO is a SME Book Built Issue proposed to list at NSE SME.

  Atmastco IPO Zenith Drugs IPO
Logo Atmastco IPO Logo Zenith Drugs IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Book Built Issue
Listing At NSE SME NSE SME
Lead Managers Affinity Global Capital Market Private Limited Gretex Corporate Services Limited
Registrar Cameo Corporate Services Limited Bigshare Services Pvt Ltd
Market Maker Asnani Stock Broker Private Limited Gretex Share Broking Private Limited
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Atmastco IPO is up to ₹56.25 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹40.68 Cr. The final issue price of Atmastco IPO is ₹77.00 per share and of Zenith Drugs IPO is ₹79.00 per share.

  Atmastco IPO Zenith Drugs IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower) ₹75.00 per share
Issue Price (Upper) ₹79.00 per share
Issue Price (Final) ₹77.00 per share ₹79.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 1600 shares 1600 shares
Fresh Issue Size 54,80,000 shares 51,48,800 shares
Fresh Issue Size (Amount) up to ₹42.20 Cr up to ₹40.68 Cr
OFS Issue Size 18,25,600 shares
OFS Issue Size (Amount) up to ₹14.06 Cr
Issue Size Total 73,05,600 shares 51,48,800 shares
Issue Size Total (Amount) up to ₹56.25 Cr up to ₹40.68 Cr

IPO Timetable

Atmastco IPO opens on Feb 15, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Atmastco IPO and Zenith Drugs IPO is Feb 20, 2024, and Feb 22, 2024, respectively.

  Atmastco IPO Zenith Drugs IPO
Anchor Bid Date Feb 16, 2024
Issue Open Feb 15, 2024 Feb 19, 2024
Issue Close Feb 20, 2024 Feb 22, 2024
Basis Of Allotment (Tentative) Feb 21, 2024 Feb 23, 2024
Initiation of Refunds (Tentative) Feb 22, 2024 Feb 26, 2024
Credit of Share (Tentative) Feb 22, 2024 Feb 26, 2024
Listing date (Tentative) Feb 23, 2024 Feb 27, 2024
Anchor Lockin End date 1 Mar 24, 2024
Anchor Lockin End date 2 May 23, 2024

Financials

Atmastco IPO P/E ratio is 11.6, as compared to Zenith Drugs IPO P/E ratio of 18.4.

  Atmastco IPO Zenith Drugs IPO
Financial

Atmastco Limited Financial Information (Restated Consolidated)

Atmastco Limited's revenue increased by 156.43% and profit after tax (PAT) rose by 295.58% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Aug 202331 Mar 202331 Mar 202231 Mar 2021
Assets24,391.5623,620.7213,273.9412,036.21
Revenue6,700.1624,278.769,468.146,990.68
Profit After Tax628.741,277.75323.0060.46
Net Worth6,259.035,520.334,235.233,912.23
Reserves and Surplus4,763.724,039.202,754.102,431.10
Total Borrowing7,317.467,125.685,155.925,410.48
Amount in ₹ Lakhs

Zenith Drugs Limited Financial Information (Restated Consolidated)

Zenith Drugs Limited's revenue increased by 24.85% and profit after tax (PAT) rose by 64.7% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended30 Sep 202331 Mar 202331 Mar 2022
Assets11,249.049,793.836,858.47
Revenue6,948.4311,569.659,266.63
Profit After Tax539.38515.29312.86
Net Worth2,264.961,724.421,209.09
Reserves and Surplus1,064.961,684.421,169.09
Total Borrowing2,902.812,605.031,880.86
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 97.39% 100.00%
Promoter Shareholding (Post-Issue) 68.43% 69.98%
P/E Ratio 11.6 18.4
Market Cap ₹190.46 Cr. ₹135.48 Cr.
ROE 23.15%% 35.13%%
ROCE 29.91%% 37.29%%
Debt/Equity 0.48 1.51
EPS ₹6.64 ₹4.29
RoNW 23.15%% 29.88%%

Shares Offered

In the Atmastco IPO retail investors (RII) are offered 34,69,600 shares while in Zenith Drugs IPO retail investors are offered 34,69,600 shares. Qualified institutional buyers (QIB) are offered 0 shares in Atmastco IPO and 8,59,200 shares in Zenith Drugs IPO.

  Atmastco IPO Zenith Drugs IPO
Anchor Investor Reserveration 12,88,000 shares
Market Maker Reserveration 3,66,400 shares 8,52,800 shares
QIB 0 shares 8,59,200 shares
NII 34,69,600 shares 6,44,800 shares
RII 34,69,600 shares 15,04,000 shares
Employee 0 shares 0 shares
Others
Total 69,39,200 shares 30,08,000 shares

Bids Received (Subscription)

Atmastco IPO subscribed 17.61x in total, whereas Zenith Drugs IPO subscribed 179.18x.

  Atmastco IPO Zenith Drugs IPO
QIB (times) 106.72x
NII (times) 14.92x 368.77x
Big NII (times)
Small NII (times)
RII (times) 18.24x 139.28x
Employee (times)
Other (times)
Total (times) 17.61x 179.18x

Comments

Add a public comment...